Physician profile
Kian Ehsan
NPI 1639349921
$6,070.19
in general payments reported to CMS, 2019-2025
22 companies · $1,804 in 2025
The $1,804 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $258 · 2021: $295 · 2022: $147 · 2023: $160 · 2024: $2,831 · 2025: $1,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,888 · Food and Beverage: $1,907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,888.13 |
| Food and Beverage | $1,907.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,449.22 | 2024-2025 | Aveir, Esprit |
| Abiomed | $544.53 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $389.11 | 2019-2020 | |
| Medtronic, INC. | $355.22 | 2021-2025 | Symplicity G3, Micra, Cobalt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $241.28 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $200.62 | 2019-2021 | |
| Boston Scientific Corporation | $142.05 | 2020-2025 | Watchman Flx, General - Vascular Intervention, Ranger |
| Impulse Dynamics (USA) INC. | $129.14 | 2024 | Optimizer |
| Amgen INC. | $127.70 | 2024-2025 | Repatha, Repatha |
| Shockwave Medical, INC | $85.20 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
| Philips North America LLC | $74.59 | 2022-2025 | Philips Laser System, Intrasight 2 Mobile |
| Baxter Healthcare | $61.14 | 2022 | |
| Welch Allyn | $61.14 | 2021 | |
| Scpharmaceuticals INC. | $45.47 | 2025 | |
| Cardiovascular Systems INC. | $38.99 | 2019-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $27.09 | 2025 | Nimbl, Flexitouch Plus |
| Astrazeneca Pharmaceuticals Lp | $20.78 | 2019 | |
| Lilly USA, LLC | $19.75 | 2025 | Zepbound |
| Terumo Medical Corporation | $18.20 | 2021 | |
| Merck Sharp & Dohme LLC | $15.14 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.39 | 2019 | |
| Ekos Corporation | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kian Ehsan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.